Biomarker predictors of outcome from a randomized trial of nivolumab +/- stereotactic body radiotherapy (SBRT) in metastatic (M1) head and neck squamous cell carcinoma (HNSCC) Meeting Abstract


Authors: McBride, S. M.; Lee, N. Y.; Pfister, D. G.; Sherman, E. J.; Tsai, C. J.; Aghalar, J.; Eng, J.; Zhi, W. I.; McFarland, D. C.; Michel, L. S.; Dunn, L.; Ho, A. L.; Riaz, N.
Abstract Title: Biomarker predictors of outcome from a randomized trial of nivolumab +/- stereotactic body radiotherapy (SBRT) in metastatic (M1) head and neck squamous cell carcinoma (HNSCC)
Meeting Title: 55th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 37
Issue: 15 Suppl.
Meeting Dates: 2019 May 31-Jun 4
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2019-05-20
Start Page: 357s
Language: English
ACCESSION: WOS:000487345806028
DOI: 10.1200/JCO.2019.37.15_suppl.6063
PROVIDER: wos
Notes: Meeting Abstract: 6063 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Loren Michel
    63 Michel
  2. Eric J Sherman
    349 Sherman
  3. Nadeem Riaz
    423 Riaz
  4. Nancy Y. Lee
    891 Lee
  5. David G Pfister
    390 Pfister
  6. Alan Loh Ho
    245 Ho
  7. Juliana Wai Ming Eng
    46 Eng
  8. Sean Matthew McBride
    303 McBride
  9. Lara   Dunn
    142 Dunn
  10. Chiaojung Jillian   Tsai
    239 Tsai
  11. Wanqing Iris Zhi
    48 Zhi